Revelation Biosciences REVB
NASDAQ REVB
$0.77 -0.03 (-3.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Revelation Biosciences (REVB) Short-term Investments (2020 - 2021)

Updated

Revelation Biosciences (REVB) recorded Short-term Investments of $19,749 in Q3 2021, down 93.5% from the prior quarter.

Analysis

Revelation Biosciences (REVB) Short-term Investments (2020 - 2021) Analysis & Trends

At the end of FY2020, Revelation Biosciences reported Short-term Investments of $525,287.

  • Per Business Quant, the preceding three quarters came in at $301,716 (Q2 2021), $390,649 (Q1 2021) and $525,287 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Revelation Biosciences 3.13 Mn -45.90 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 19,749.00
Jun 30, 2021 301,716.00
Mar 31, 2021 390,649.00
Dec 31, 2020 525,287.00
API Access

Revelation Biosciences Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=REVB&period=max&api_key=YOUR_API_KEY